Experts at Yale Cancer Center highlight ongoing trials intended to improve outcomes across mantle cell lymphoma, T-cell lymphoma, and other populations.
Tarsheen Sethi, MD, MSc
Advertisement
Articles by Tarsheen Sethi, MD, MSc
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Iberdomide Combo in Relapsed/Refractory Multiple Myeloma
2
Iza-Bren Yields Encouraging Activity in Extensive-Stage SCLC
3
How AI and Health Networks Are Democratizing Clinical Trial Access
4
Zipalertinib Combo Meets PFS End Point in First-Line EGFR Exon 20 NSCLC
5